Bonfire of the Vanities: The Difference Between Marketing and Sales in Tech

When I was in my 20s, I was taught the relationship between marketing and sales over a bonfire. — Over 30 years ago, before the arrival of the personal computer, there were desktop computers called office workstations. Designed around the first generation of microprocessors, these computers ran business applications like word processing, spreadsheets, and accounting. … Continue reading “Bonfire of the Vanities: The Difference Between Marketing and Sales in Tech”

Radio Without Radios, Books Without Bookstores: Welcome to the Era of Unbound Media

Last weekend I decided to get serious about the fact that I live in an earthquake zone, and started putting together a kit with all the food, water, and equipment I’d need to survive for a few days if local services broke down. One of the items that turns up on all of the standard … Continue reading “Radio Without Radios, Books Without Bookstores: Welcome to the Era of Unbound Media”

Rox Medical Garners $4,000,000 New Round

Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=8cc03c01-0b3b-4349-8fcc-221f15564bab&Preview=1 Date 8/5/2011 Company Name Rox Medical Mailing Address 150 Calle Iglesia San Clemente, CA 92672 Company Description ROX Medical is an early phase medical device company that is pioneering an innovative treatment for Chronic Obstructive Pulmonary Disease (COPD). Our therapy is intended to improve the delivery of oxygen to tissue to … Continue reading “Rox Medical Garners $4,000,000 New Round”

On Deck Capital Receives $4,000,000 Series C Round

Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=445a9996-3a5f-4b16-a214-686d4641ad52&Preview=1 Date 8/5/2011 Company Name On Deck Capital Mailing Address 13807 Ventura Blvd. Sherman Oaks, CA 91423 Company Description On Deck Capital was founded in 2006 to help businesses get small business loan financing when traditional bank loans are not an option. Our vision is to help small businesses get access to … Continue reading “On Deck Capital Receives $4,000,000 Series C Round”

Amylin & Takeda Halt Obesity Drug Development

[Updated 8/4/11, 6:55 pm. See below.] San Diego’s Amylin Pharmaceuticals (NASDAQ: [[ticker:AMLN]]) and Japan’s Takeda Pharmaceutical threw in the towel today, saying they are discontinuing development of pramlintide/metreleptin for the treatment of obesity. [Updated 8/4/11, 6:55 pm to clarify explanation] Observers feared something like this might happen in March, when Takeda and Amylin suspended a … Continue reading “Amylin & Takeda Halt Obesity Drug Development”

FDA OKs Changes in Santarus Heart Study

The FDA has agreed to protocol changes in a late stage clinical trial of a new heart drug being developed by San Diego-based Santarus (NASDAQ: [[ticker:SNTS]]) and the Netherlands-based Pharming Group under a special protocol assessment (SPA). The FDA sought modifications to the study of a recombinant human C1 inhibitor (Rhucin) as a treatment for … Continue reading “FDA OKs Changes in Santarus Heart Study”

$6M Sweet Music for TakeLessons

After taking $20,000 as the winner of the San Diego Venture Group’s Pitchfest Biz Plan Competition in December, San Diego-based TakeLessons said it has raised $6 million in venture funding led by San Francisco-based Crosslink Capital. SoftTech VC of Palo Alto, CA, and angel investors joined in the early stage round. Founded in 2006 by … Continue reading “$6M Sweet Music for TakeLessons”

Vertex Sales Much Bigger Than Expected, Amylin Re-Submits Exenatide, Mini VC Fund Debuts, & More San Diego Life Sciences News

If there’s a common thread in San Diego’s biotech news over the past week, it would be perseverance. If you can persist with our briefing, you’ll see what I mean. —Cambridge, MA-based Vertex, (NASDAQ: [[ticker:VRTX]]), which has a sizable presence in San Diego, said it generated $74.5 million in second-quarter sales of telaprevir (Incivek), its … Continue reading “Vertex Sales Much Bigger Than Expected, Amylin Re-Submits Exenatide, Mini VC Fund Debuts, & More San Diego Life Sciences News”

Xconomist of the Week: Five Questions About Life Sciences Investing for Dennis Purcell of Aisling Capital

Dennis Purcell is the senior managing partner of New York-based Aisling Capital, one of the top venture capital firms in the life sciences industry, with $1.65 billion under management. In 2009, Aisling closed its third fund, worth $650 million. Aisling Capital’s first fund started up in 2002 with the goal of supporting startups across the … Continue reading “Xconomist of the Week: Five Questions About Life Sciences Investing for Dennis Purcell of Aisling Capital”

BrainCells Raises $1M, Moving Ahead Without CEO Schoeneck or CSO Barlow

At this time last year, Luke reported that San Diego’s BrainCells Inc. had acquired the compound sabcomeline from London-based Proximagen, and planned to study the drug as a treatment for depression. Just a couple of months earlier, we reported that BrainCells was at a crossroads after a clinical trial showed that its lead compound for … Continue reading “BrainCells Raises $1M, Moving Ahead Without CEO Schoeneck or CSO Barlow”

San Diego’s Eventful Looks to Put Consumers in Charge, with Backward Glance at eBay

[Corrected 8/8/11, 11:35 am. See below.] Eventful CEO Jordan Glazier likes to describe the San Diego Web-based startup as an “eBay for local events and entertainment,” and there are more than a few similarities. One of them is Glazier himself. Before joining Eventful in 2006, he spent five years as a general manager at the … Continue reading “San Diego’s Eventful Looks to Put Consumers in Charge, with Backward Glance at eBay”

Cleantech Investing Stagnates, But California Clings to Lead

So far this year, venture investments in cleantech and alternative energy aren’t keeping up with the optimistic pace set in 2010. While total U.S. cleantech investments in the second quarter were up slightly from the quarter before—$1.093 billion, versus $1.014 billion—they’re lagging 44 percent behind the quarterly record set one year ago, in the second … Continue reading “Cleantech Investing Stagnates, But California Clings to Lead”

SD’s iHub Expanded to Riverside

A state initiative intended to facilitate technology commercialization by designating regional iHubs (or innovation hubs) has expanded San Diego’s iHub to include much of Southwest Riverside County. The California Governor’s Office of Economic Development established the San Diego iHub last year, enabling a local consortium to apply for federal economic stimulus funding in three focus … Continue reading “SD’s iHub Expanded to Riverside”

TakeLessons Garners $6,000,000 New Round

Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=bb0af398-0238-4b37-beea-f356be789719&Preview=1 Date 8/3/2011 Company Name TakeLessons Mailing Address 517 Fourth Ave San Diego, CA 92101 Company Description TakeLessons is America’s full-service music and voice lessons provider. It was founded in 2004 to help people discover their creativity and pursue their passions. With lessons taught by Certified TakeLessons™ instructors in thousands of cities … Continue reading “TakeLessons Garners $6,000,000 New Round”

Indie Game Studio Sucker Punch Gobbled by Sony, Will Stay in Seattle Area

Bellevue, WA’s Sucker Punch Productions is heading to the mothership. After a longtime partnership developing games for Sony’s PlayStation consoles, Sucker Punch will become Sony Computer Entertainment’s 16th studio. Terms of the acquisition weren’t disclosed, but Sony says Sucker Punch will keep its current headquarters. Sucker Punch, founded in 1997 by former Microsofties, is known … Continue reading “Indie Game Studio Sucker Punch Gobbled by Sony, Will Stay in Seattle Area”

You’d Better Shop Around: Doing Due Diligence on Your VC

For a first-time entrepreneur, dealing with a venture capitalist can involve an equal mix of excitement and apprehension. If the VC has any sort of reputation or prominence, entrepreneurs are often grateful simply to be pitching their idea in the first place. Should discussions get far enough along that a term sheet is offered, a … Continue reading “You’d Better Shop Around: Doing Due Diligence on Your VC”

San Diego’s Moore Venture Partners Seeks a Niche Amid Local VC Decline

Can a small venture firm make much of a difference in stemming the general decline that has marked venture capital funding in San Diego’s innovation economy over the past five or six years? A one-person firm created last year may not exactly fill the void in San Diego, but founder Terry Moore argues that he … Continue reading “San Diego’s Moore Venture Partners Seeks a Niche Amid Local VC Decline”

Arena Passes Small Study, in Bid to Answer FDA Questions About Obesity Drug

[Updated: 9:50 am ET] San Diego-based Arena Pharmaceuticals faces a lot of questions that need to be answered before it can hope to win FDA clearance to sell its obesity pill. Now the drug developer says it has at least one piece of the puzzle it hopes will satisfy U.S. drug regulators. Arena (NASDAQ: [[ticker:ARNA]]) … Continue reading “Arena Passes Small Study, in Bid to Answer FDA Questions About Obesity Drug”

BetterWorks Secures $8,000,000 Series A Round

Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=be6df7c9-0815-4174-8507-a6d4003ce731&Preview=1 Date 8/2/2011 Company Name BetterWorks Mailing Address 1337 3rd Street Santa Monica, CA 90401 Company Description BetterWorks vision is to “Make Work Rewarding!” Technically speaking we’re a business platform where businesses can quickly create better, more rewarding work environments for their employees while saving a ton of time and money. Website … Continue reading “BetterWorks Secures $8,000,000 Series A Round”

Malama Composites Lands $695,699 New Financing Round

Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=03d32df4-0451-4ed9-98e4-d0501288e0ae&Preview=1 Date 8/2/2011 Company Name Malama Composites Mailing Address 10326 Roselle St San Diego, CA 92121 Company Description The mission of the company is to develop and manufacture core materials that enable our customers to produce strong, light-weight, high performance, competitively priced, environmentally superior products. Malama Composites embraces triple bottom line business … Continue reading “Malama Composites Lands $695,699 New Financing Round”

Fallbrook Names President

San Diego’s Fallbrook Technologies, which has been developing a continuously variable transmission, today named Al Kammerer as president, a newly created position. Kammerer, who spent 34 years with the Ford Motor Co., will report to William G. Klehm, Fallbrook’s chairman and CEO. Kammerer, who has been a Fallbrook board member since 2009, will oversee the … Continue reading “Fallbrook Names President”

CMEA’s Jain on San Diego’s Innovation Economy, E&Y Reports on IPO Activity, Wildcat Discovery Gets $7.5M, & More San Diego BizTech News

We saw a potpourri of tech news in San Diego last week, which included funding for an emerging cleantech startup, new technology from Tealium, and an acquisition by Qualcomm. Our briefing begins now. —CMEA Capital’s Sumeet Jain offered his perspective on what’s missing, besides capital, from the tech sector of San Diego’s innovation community. Jain, … Continue reading “CMEA’s Jain on San Diego’s Innovation Economy, E&Y Reports on IPO Activity, Wildcat Discovery Gets $7.5M, & More San Diego BizTech News”

What I Learned About Healthcare as a Patient: The Delivery System Has Got to Change

You can read all the books and news stories you want on the U.S. healthcare system, and conclude it’s profoundly messed up. But sometimes there’s nothing so enlightening as first-hand experience. I’ve been thinking about how awful U.S. healthcare is the past couple weeks, based on my latest experience as a patient. It’s made me … Continue reading “What I Learned About Healthcare as a Patient: The Delivery System Has Got to Change”

NeoMend Secures $10,000,000 New Funding Round

Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=e77a516e-cdff-41ab-a265-fe2a6faa6789&Preview=1 Date 8/1/2011 Company Name NeoMend Mailing Address 60 Technology Drive Irvine, CA 92618 Company Description NeoMend, Inc. is a privately held, clinical stage biomedical device company engaged in the development and commercialization of advanced surgical wound healing products. Website http://www.neomendinc.com Transaction Type Venture Equity Transaction Amount $10,000,000 Transaction Round Undisclosed Proceeds … Continue reading “NeoMend Secures $10,000,000 New Funding Round”

At 2011’s Midpoint, Three Good Tech Trends and Three Not-So-Good Trends to Watch

Mid-year reports tend to be check-ins or check-ups; and they’re usually not very interesting, analytical, or helpful. The real fireworks often take place at the end of the year, when the 12-month look-back and 12-month look-ahead forecast steals the show—in terms of shedding light, providing perspective, and setting the agenda. Not so in 2011. Here … Continue reading “At 2011’s Midpoint, Three Good Tech Trends and Three Not-So-Good Trends to Watch”

How I Decide What to Write About-And Why I Might Not Cover Your Company

Dharmesh Shah, the co-founder of HubSpot and the author of the blog OnStartups, shared a post last week that really hit home. It was called “Dear Friend: Sorry: My Heart Says Yes, But My Schedule Says No.” Dharmesh explained that his e-mail inbox is perpetually overloaded with requests from people who want to meet with … Continue reading “How I Decide What to Write About-And Why I Might Not Cover Your Company”

Oblong Industries Lands $15,575,006 New Funding Round

Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=d33c6ce8-0894-49ea-a779-b00384b8613a&Preview=1 Date 7/29/2011 Company Name Oblong Industries Mailing Address 923 E. 3rd St. Los Angeles, CA 90013 Company Description Oblong is developing gesture-recognition technologies. Website http://www.oblong.com Transaction Type Venture Equity Transaction Amount $15,575,006 Transaction Round Undisclosed Proceeds Purposes Proceeds purposes were not disclosed. SEC regulatory filing-amended. M&A Terms Venture Investor Undisclosed

Vertex Smashes Wall Street Sales Expectations In Hepatitis C Drug Debut

Vertex Pharmaceuticals is off to a running start in the marketplace with its brand new hepatitis C drug. The Cambridge, MA-based company (NASDAQ: [[ticker:VRTX]]) said today that it generated $74.5 million in sales of telaprevir (Incivek) in the quarter that ended June 30. That’s an especially big number as far as new pharmaceutical rollouts go—Wall … Continue reading “Vertex Smashes Wall Street Sales Expectations In Hepatitis C Drug Debut”

National Science Foundation Unveils a Startup School Modeled on Steve Blank’s Lean LaunchPad

Incubator madness has reached all the way to Washington, D.C. The National Science Foundation announced today that with the help of private-sector partners, it plans to put at least $5 million per year into a new program, the Innovation Corps or I-Corps, aimed at helping university scientists and engineers build startups around their technologies. The … Continue reading “National Science Foundation Unveils a Startup School Modeled on Steve Blank’s Lean LaunchPad”

Bydureon Sent Back to FDA

San Diego-based Amylin Pharmaceuticals (NASDAQ: [[ticker:AMLN]]), Indianapolis-based Eli Lilly (NYSE: [[ticker:LLY]]), and Waltham, MA-based Alkermes (NASDAQ: [[ticker:ALKS]]) said today that they have re-submitted an application to the FDA, for clearance to start marketing exenatide once-weekly (Bydureon) as a new treatment for diabetes in the U.S. The agency turned down an earlier application, asking the companies … Continue reading “Bydureon Sent Back to FDA”

Trius and Bayer Sign Deal, Brooks Buys Nexus Biosystems, Wildcat Discovery Gets $7.5M Financing, & More San Diego Life Sciences News

Against a backdrop of rising worries over the U.S. economy, we saw San Diego life science companies forming new partnerships, raising new funding, and closing some new deals over the last week. We also saw drops in share prices at two of our biggest life science companies. Your briefing is ready now. —San Diego’s Trius … Continue reading “Trius and Bayer Sign Deal, Brooks Buys Nexus Biosystems, Wildcat Discovery Gets $7.5M Financing, & More San Diego Life Sciences News”

A Bay Area VC Sees Some Missing Ingredients in San Diego’s Innovation Community

As we saw in the venture activity surveys that came in last week, the capital deployed by VC firms in startups developing innovative technologies has been returning to pre-recession levels in key technology hubs throughout the United States. In San Diego, however, venture funding has taken a decided turn for the life sciences. Of the … Continue reading “A Bay Area VC Sees Some Missing Ingredients in San Diego’s Innovation Community”

Trius Strikes Antibiotic Deal With Bayer, Pockets $25M

San Diego-based Trius Therapeutics, the developer of a new antibiotic, said today it has secured its first big commercial partnership to market the experimental drug around the world. Trius (NASDAQ: [[ticker:TSRX]]) said today that it has provided an exclusive license to Germany-based Bayer to develop and market torezolid phosphate in China, Japan, Africa, Latin America, … Continue reading “Trius Strikes Antibiotic Deal With Bayer, Pockets $25M”

Health IT Is the New Black

Once upon a time there was “ehealth.” That time was the late 1990’s and there was a temporary ripple in The Force when anything that combined healthcare and the Internet had a suddenly popularity in the venture capital investment community. Companies like the original WebMD, the original Medscape, Mediconsult.com, DrKoop.com, Medibuy, Adam.com, PlanetRx, and a … Continue reading “Health IT Is the New Black”

Brooks Acquires San Diego’s Nexus Biosystems for $79M

Brooks Automation (NASDAQ: [[ticker:BRKS]]), the biomedical equipment maker in Chelmsford, MA, says today it paid $79 million to acquire Nexus Biosystems, a suburban San Diego provider of compound sample management systems. Based in Poway, CA, about 19 miles north of San Diego, Nexus makes automated equipment for handling chemical and biological samples in a variety … Continue reading “Brooks Acquires San Diego’s Nexus Biosystems for $79M”

Novira Therapeutics Secures $2,500,000 New Round

Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=cec930b4-2f0a-4a4e-ab53-f89ff7e904f9&Preview=1 Date 7/27/2011 Company Name Novira Therapeutics Mailing Address Undisclosed Los Angeles, CA 90041 Company Description Novira is an antiviral drug discovery company launched in 2009 that is focused on the discovery of novel, first-in-class therapeutics for the treatment of HBV and HIV, two global diseases in need of better therapies. The … Continue reading “Novira Therapeutics Secures $2,500,000 New Round”

Brooks Automation Acquires Nexus Biosystems for $86,700,000

Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=e141af58-fb37-4884-9ccd-04e03eff0084&Preview=1 Date 7/27/2011 Company Name Nexus Biosystems Mailing Address 12140 Community Road Poway, CA 92064 Company Description NEXUS Biosystems, a privately held company based in Poway, California, USA, has since 1996 been a developer and provider of enabling technologies and automation systems for pharmaceutical, biotech, agrochemical and academic research institutions worldwide. Website … Continue reading “Brooks Automation Acquires Nexus Biosystems for $86,700,000”

IPO Activity Returns to Pre-Recession Levels in Second Quarter

The economic deep freeze is thawing for IPOs on U.S. exchanges, according to a quarterly report issued today by the Ernst & Young accounting firm. The number of companies in registration for an initial public offering increased to 140 during the three months that ended June 30, according to the latest the “Ernst & Young … Continue reading “IPO Activity Returns to Pre-Recession Levels in Second Quarter”

Illumina Sales Climb 36%, Profits Flat

San Diego-based Illumina (NASDAQ: [[ticker:ILMN]]), the market-leading maker of gene sequencing instruments, said today that its sales climbed 36 percent, to $287.5 million, in the quarter that ended June 30. The company turned a profit of $30.6 million in the quarter, a 2.7 percent increase compared with the $29.8 million profit in the same period … Continue reading “Illumina Sales Climb 36%, Profits Flat”

Wildcat Discovery Raises $7.5M to Develop Advanced Cleantech Materials

Wildcat Discovery Technologies, a five-year-old San Diego startup applying high-throughput screening technologies in cleantech materials development, has raised $7.5 million through a combination of equity, convertible debt, and securities, according to a recent regulatory filing. The total includes $685,000 in warrants convertible to preferred shares. Wildcat’s work is focused on identifying and developing new materials … Continue reading “Wildcat Discovery Raises $7.5M to Develop Advanced Cleantech Materials”

San Diego’s Tealium Unveils New System to Manage Tracking Code in Web Pages

Tealium co-founder Ali Behnam tells me their San Diego startup began three years ago as an IT consulting firm, and soon ran into a lot of clients who needed their help to address a variety of headaches associated with managing all the page tags on a company website. The tracking code that makes up these … Continue reading “San Diego’s Tealium Unveils New System to Manage Tracking Code in Web Pages”

Wildcat Discovery Technologies Receives $6,850,000 New Funding Round

Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=91581696-49b9-4fb0-8c39-b5f80aa0468d&Preview=1 Date 7/26/2011 Company Name Wildcat Discovery Technologies Mailing Address 6985 Flanders Drive San Diego, CA 92121 Company Description A start-up company focused on the discovery of advanced materials for clean energy technology applications, Wildcat Discovery Technologies, Inc. has developed high throughput synthesis and screening platforms for rapid evaluation and discovery of … Continue reading “Wildcat Discovery Technologies Receives $6,850,000 New Funding Round”

ThinkNear Garners $1,600,000 New Financing

Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=a737aa9a-f915-4af3-abcf-f3f0648409cc&Preview=1 Date 7/26/2011 Company Name ThinkNear Mailing Address Undisclosed Los Angeles, CA 90001 Company Description We started ThinkNear because we love local businesses and didn’t think there were any good marketing solutions out there that helped get customers at the right time, with the lowest cost, and with zero effort. Website http://www.thinknear.com … Continue reading “ThinkNear Garners $1,600,000 New Financing”

CareFusion Gets Exclusive 5-Year Deal for ResMed Ventilators

Two of San Diego’s biggest medical device companies, CareFusion (NYSE: [[ticker:CFN]]) and ResMed (NYSE: [[ticker:RMD]]), today announced a five-year agreement that gives CareFusion exclusive rights to distribute two ResMed non-invasive ventilators and accessories in the United States. ResMed said the deal enables it to use CareFusion’s extensive sales network of U.S. hospitals, long-term acute care … Continue reading “CareFusion Gets Exclusive 5-Year Deal for ResMed Ventilators”

Qualcomm’s GestureTek Deal Signals New Possibilities for Qualcomm Atheros

Qualcomm (NASDAQ: [[ticker:QCOM]]), the San Diego wireless technologies giant, said today it has acquired certain assets related to gesture recognition technology from Sunnyvale, CA-based GestureTek—a move that points to new capabilities at its new Atheros unit. Financial terms of the deal were not disclosed. GestureTek, founded in 1986, specializes in machine vision technology that enables … Continue reading “Qualcomm’s GestureTek Deal Signals New Possibilities for Qualcomm Atheros”

Life Sciences Firms Grab VC Dollars, ViaSat-1 Ready for Launch, EarthRisk Offers 40-Day Forecasts, & More San Diego BizTech News

While venture capital activity remained relatively constant in year-over-year funding for San Diego companies, most of the capital went to local life sciences companies. It was a big week for VC news, and our briefing begins now. —A regional breakout of venture activity from the MoneyTree Report shows that 29 startups in San Diego received … Continue reading “Life Sciences Firms Grab VC Dollars, ViaSat-1 Ready for Launch, EarthRisk Offers 40-Day Forecasts, & More San Diego BizTech News”

The Man Behind the Magic

This past week was truly a “magical” one for me. Earvin “Magic” Johnson, the hall of fame basketball star, brilliant entrepreneur, and generous philanthropist joined my venture capital firm, Detroit Venture Partners, as our fourth partner. Spending the day with Earvin reveals something much more than his legendary stats and accomplishments, however. His rarified level … Continue reading “The Man Behind the Magic”

The CliffsNotes Version of True University—The 2-Day Startup School from True Ventures

After I wrote a long article profiling the unusual culture at True Ventures, the San Francisco-based early stage investing fund known for its investments in startups like Automattic, GigaOm, and KissMetrics, the firm invited me to attend True University, a two-day conference on startup-building tactics at the University of California at Berkeley. (Well, the truth … Continue reading “The CliffsNotes Version of True University—The 2-Day Startup School from True Ventures”

Dow Jones Shows Slight Decline in Venture Deals, Dollars, Since Last Year

More or less correlating the results of two previous venture capital surveys, Dow Jones VentureSource says today that venture investors throughout the United States put $8 billion into 776 deals during the second quarter that ended June 30. In terms of absolute numbers, that’s fairly close to venture data we reported Wednesday from the MoneyTree … Continue reading “Dow Jones Shows Slight Decline in Venture Deals, Dollars, Since Last Year”